SCHEMBL6982640

SCHEMBL6982640

O=c1ncscn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5421586 0.63
SCHEMBL7964249 0.57 TSHR (0.50)
SCHEMBL9246090 0.54
SCHEMBL7885852 0.54
SCHEMBL9564850 0.54
SCHEMBL446727 0.54
Hydrochloric Acid SCHEMBL8314010 0.48
SCHEMBL10982343 0.48
SCHEMBL1157926 0.42
SCHEMBL1292065 0.42

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1854135-A Heteronuclear compound with dicyandiamide connection and its medicinal use LI WEIZHANG (CN) 2006-11-01 CN claimed
JP-2115159-A None JP disclosed
JP-2101069-A None JP disclosed
CN-1854135-B Heteronuclear compound with dicyandiamide connection and its medicinal use LI WEIZHANG 2013-06-12 CN disclosed
CN-1854135-A Heteronuclear compound with dicyandiamide connection and its medicinal use LI WEIZHANG (CN) 2006-11-01 CN disclosed
EP-0846111-B1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMA (US) 2003-08-27 EP disclosed
EP-1109560-B1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-20030138432-A1 Selective cellular targeting: multifunctional delivery vehicles, multifunctional prodrugs, use as antineoplastic drugs DRUG INNOVATION & DESIGN, INC. 2003-07-24 US disclosed
US-20020173515-A1 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds VARNEY MICHAEL D (US) 2002-11-21 US disclosed
EP-1255567-A1 SELECTIVE CELLULAR TARGETING: MULTIFUNCTIONAL DELIVERY VEHICLES Drug Innovation &amp; Design, Inc. (US) 2002-11-13 EP disclosed
CN-1026587-C Process for preparing 1, 3, 5-thiadiazin-4-one derivatives KOREA CHEMICAL INSTITUDE (KR) 1994-11-16 CN disclosed
CN-1026587-C Process for preparing 1, 3, 5-thiadiazin-4-one derivatives KOREA CHEMICAL INSTITUDE (KR) 1994-11-16 CN disclosed
WO-1994013295-A1 ANTIPROLIFERATIVE SUBSTITUTED 5-THIAPYRIMIDINONE AND 5-SELENOPYRIMIDINONE COMPOUNDS AGOURON PHARMACEUTICALS, INC. (US) 1994-06-23 WO disclosed
US-5284844-A 3,5-Dihalogeno-1,2,6-thiadiazin-4-ones FMC CORPORATION (US) 1994-02-08 US disclosed
US-5077423-A Intermediates for 1,3,5-thiadiazine-4-one derivatives KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 1991-12-31 US disclosed
US-5077423-A Intermediates for 1,3,5-thiadiazine-4-one derivatives KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 1991-12-31 US disclosed
JP-H02115159-A S-(N-ALKOXYCARBONYL-N-SUBSTITUTED)AMINOMETHYL ISOTHIOUREA DERIVATIVE KOREA RES INST CHEM TECHNOL 1990-04-27 JP disclosed
JP-H02101069-A 1,3,5-THIADIAZIN-4-ONE DERIVATIVE, PRODUCTION THEREOF AND INSECTICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT SUMITOMO CHEM CO LTD 1990-04-12 JP disclosed
EP-0358416-A1 S-(N-alkoxycarbonyl, N-substituted) amino-methyl isothiourea derivative KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 1990-03-14 EP disclosed
EP-0358416-A1 S-(N-alkoxycarbonyl, N-substituted) amino-methyl isothiourea derivative KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 1990-03-14 EP disclosed